What clinicians need (and want!) to know about the health economic profile of new pharmaceuticals

Health economic evaluations and Health Technology Assessment are increasingly used in decisions on market access for medicines and medtech solutions. But market access does not automatically mean patient access. In order to enable patients to benefit from truly innovative medicines and medtech solutions, also clinicians need to understand their value and value for money.

In this webinar, dated 29 November 2021,  Prof. Lieven Annemans, faculty member of CELforPharma's courses on the Fundamentals of Health Economics and Health Technology Assessment, provides his insights as to what the principles and methods of health economic evaluations mean for clinicians and patients:

  • How to talk about value for money

  • How to align clinical & economic perspectives

  • How to deal with evidence gaps


PS: You will only have to submit your email address, name and company, after clicking on the video to watch this webinar.



Learn more about this topic at the following short duration course(s):



Subscribe to CELforPharma's newsletter to receive tips & insights from our expert faculty:


Please indicate your domains of interest:

Interested in domains

By subscribing to this newsletter, I accept the Privacy Policy.